Espinosa A - Search Results

1

Implementing a patient blood management program in Norway: Where to start?

Espinosa A, Arsenovic M, Hervig T, Sundic T, Aandahl A, Kronborg J, Seghatchian J. Espinosa A, et al. Transfus Apher Sci. 2016 Jun;54(3):422-7. doi: 10.1016/j.transci.2016.05.015. Epub 2016 May 12. Transfus Apher Sci. 2016. PMID: 27216542 Review.

2

What is happening? The evolving role of the blood bank in the management of the bleeding patient: The impact of TEG as an early diagnostic predictor for bleeding.

Espinosa A, Seghatchian J. Espinosa A, et al. Transfus Apher Sci. 2014 Dec;51(3):105-10. doi: 10.1016/j.transci.2014.10.017. Epub 2014 Nov 4. Transfus Apher Sci. 2014. PMID: 25457003 Review.

3

Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations.

Espinosa A, Hjorth-Hansen H, Aasly K, Teigum I, Sivertsen G, Seghatchian J. Espinosa A, et al. Transfus Apher Sci. 2015 Aug;53(1):88-91. doi: 10.1016/j.transci.2015.05.014. Epub 2015 May 19. Transfus Apher Sci. 2015. PMID: 26027793 Review.

4

Quality, safety and sustained therapeutic efficacy of blood-derived serum eye drops to treat dry eye syndrome: R&D road map for future progress.

Seghatchian J, Espinosa A, Burnouf T. Seghatchian J, et al. Among authors: espinosa a. Transfus Apher Sci. 2016 Feb;54(1):168-9. doi: 10.1016/j.transci.2016.01.023. Epub 2016 Jan 15. Transfus Apher Sci. 2016. PMID: 26818750 Review. No abstract available.

5

Commentary on technical specifications and safety requirements of serum eye drops: Keeping a close eye on the content in cytokines.

Seghatchian J, Espinosa A, Burnouf T. Seghatchian J, et al. Among authors: espinosa a. Transfus Apher Sci. 2016 Feb;54(1):170-1. doi: 10.1016/j.transci.2016.01.024. Epub 2016 Jan 15. Transfus Apher Sci. 2016. PMID: 26847867 Review. No abstract available.

6

The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti-D prophylaxis.

Sørensen K, Baevre MS, Tomter G, Llohn AH, Hagen KG, Espinosa A, Jacobsen B, Arsenovic MG, Sørvoll IH, Ulvahaug AN, Sundic T, Akkök ÇA. Sørensen K, et al. Among authors: espinosa a. Transfus Med. 2021 Oct;31(5):314-321. doi: 10.1111/tme.12772. Epub 2021 Apr 5. Transfus Med. 2021. PMID: 33821537

7

Hemovigilance in Norway.

Espinosa A, Steinsvåg CT, Flesland O. Espinosa A, et al. Transfus Apher Sci. 2005 Feb;32(1):17-9. doi: 10.1016/j.transci.2004.06.010. Transfus Apher Sci. 2005. PMID: 15737868 Review. No abstract available.

8

Implementation of a protocol for prehospital transfusion of low-titer, leukocyte-depleted whole blood for civilian bleeding patients.

Espinosa A, Dybvik B, Medby C, Vangberg G. Espinosa A, et al. Transfus Apher Sci. 2019 Apr;58(2):212-215. doi: 10.1016/j.transci.2019.03.012. Epub 2019 Mar 20. Transfus Apher Sci. 2019. PMID: 30910615 Review.

9

Eight years with haemovigilance in Norway. What have we learnt?

Steinsvåg CT, Espinosa A, Flesland Ø. Steinsvåg CT, et al. Among authors: espinosa a. Transfus Apher Sci. 2013 Dec;49(3):548-52. doi: 10.1016/j.transci.2013.09.013. Epub 2013 Oct 10. Transfus Apher Sci. 2013. PMID: 24157220

10

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment.

Osselaer JC, Messe N, Hervig T, Bueno J, Castro E, Espinosa A, Accorsi P, Junge K, Jacquet M, Flament J, Corash L. Osselaer JC, et al. Among authors: espinosa a. Transfusion. 2008 Jun;48(6):1061-71. doi: 10.1111/j.1537-2995.2008.01643.x. Epub 2008 Mar 13. Transfusion. 2008. PMID: 18346019 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

810 results

Search Page